A NEW SURGICAL OUTCOME SCORE (SOS) INCLUDING HE4, CA125 AND ASCITES VOLUME CAN PREDICT SURGICAL OUTCOME IN PRIMARY OVARIAN CANCER PATIENTS.

被引：0
|
作者：
Braicu, E. [1 ]
van Gorp, T. [2 ]
Richter, R. [1 ]
Nassir, M. [3 ]
Zeillinger, R. [4 ]
Conicn, N. [5 ]
Tong, D. Cacsire Castillo [4 ]
Mahner, S. [6 ]
Vergote, I. [7 ]
Sehouli, J. [1 ]
机构：
[1] Charite, Dept Gynaecol, D-13353 Berlin, Germany
[2] Univ Hosp Maastricht, Dept Obstet & Gynaecol, Maastricht, Netherlands
[3] Charite Campus Virchow, Dept Gynaecol, Berlin, Germany
[4] Med Univ Vienna, Mol Oncol Grp, Vienna, Austria
[5] Med Univ Innsbruck, Dept Obstet & Gynecol, A-6020 Innsbruck, Austria
[6] Med Univ Hamburg, Clin Gynecol, Hamburg, Germany
[7] Univ Hosp KU Leuven, Dept Obstet & Gynaecol, Louvain, Belgium
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2013年 / 23卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Use of CA125 and HE4 Serum Markers to Predict Ovarian Cancer in Elevated-Risk Women
    Karlan, Beth Y.
    Thorpe, Jason
    Watabayashi, Kate
    Drescher, Charles W.
    Palomares, Melanie
    Daly, Mary B.
    Paley, Pam
    Hillard, Paula
    Andersen, M. Robyn
    Anderson, Garnet
    Drapkin, Ronny
    Urban, Nicole
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (07) : 1383 - 1393
  • [22] HE4 Expression in Plasma Correlates with Surgical Outcome and Overall Survival in Patients with First Ovarian Cancer Relapse
    Braicu, Elena Ioana
    Chekerov, Radoslav
    Richter, Rolf
    Pop, Carmen
    Nassir, Mani
    Loefgren, Hanna
    Stamatian, Florin
    Muallem, Mustafa Zelal
    Hall, Christina
    Fotopoulou, Christina
    Sehouli, Jalid
    Pietzner, Klaus
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (03) : 955 - 962
  • [23] HE4 Expression in Plasma Correlates with Surgical Outcome and Overall Survival in Patients with First Ovarian Cancer Relapse
    Elena Ioana Braicu
    Radoslav Chekerov
    Rolf Richter
    Carmen Pop
    Mani Nassir
    Hanna Loefgren
    Florin Stamatian
    Mustafa Zelal Muallem
    Christina Hall
    Christina Fotopoulou
    Jalid Sehouli
    Klaus Pietzner
    Annals of Surgical Oncology, 2014, 21 : 955 - 962
  • [24] Predicting value of HE4 and CA125 markers for optimal cytoreductive surgery in ovarian cancer patients
    Saffarieh, Elham
    Nassiri, Setare
    Mirmohammadkhani, Majid
    EUROPEAN JOURNAL OF TRANSLATIONAL MYOLOGY, 2022, 32 (03)
  • [25] Diagnostic performance of CA125, HE4, ROMA, and CPH-I in identifying primary ovarian cancer
    Luo, Hui-Jing
    Hu, Zhi-Dong
    Cui, Ming
    Zhang, Xiao-Fang
    Tian, Wen-Yan
    Ma, Chao-Qun
    Ren, Ya-Nv
    Dong, Zuo-Liang
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2023, 49 (03) : 998 - 1006
  • [26] The Performance of HE4 Alone and in Combination with CA125 for the Detection of Ovarian Cancer in an Enriched Primary Care Population
    Barr, Chloe E.
    Funston, Garth
    Jeevan, David
    Sundar, Sudha
    Mounce, Luke T. A.
    Crosbie, Emma J.
    CANCERS, 2022, 14 (09)
  • [27] HE4 and CA-125 kinetics to predict outcome in patients with recurrent epithelial ovarian carcinoma: the META4 clinical trial
    Fabbro, Michel
    Lamy, Pierre-Jean
    Touraine, Celia
    Floquet, Anne
    Ray-Coquard, Isabelle
    Mollevi, Caroline
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [28] Use of HE4 expression in plasma to predict operative outcome in patients with ovarian cancer (OC)
    Braicu, E. I.
    Zeillinger, R.
    Vergote, I. B.
    Mahner, S.
    Zeimet, A. G.
    Cadron, I.
    Castillo-Tong, D.
    Chekerov, R.
    Brandt, B.
    Sehouli, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] Serum HE4 and CA125 as predictors of response and outcome during neoadjuvant chemotherapy of advanced high-grade serous ovarian cancer
    Vallius, Tuulia
    Hynninen, Johanna
    Auranen, Annika
    Carpen, Olli
    Matomaki, Jaakko
    Oksa, Sinikka
    Virtanen, Johanna
    Grenman, Seija
    TUMOR BIOLOGY, 2014, 35 (12) : 12389 - 12395
  • [30] Serum HE4 level is an independent risk factor of surgical outcome and prognosis of epithelial ovarian cancer
    Kang, S.
    Kong, S.
    Park, S.
    Seo, S.
    Kim, J.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S77 - S77
12345